135 related articles for article (PubMed ID: 26603273)
21. Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil.
Arshad A; Chung WY; Steward W; Metcalfe MS; Dennison AR
HPB (Oxford); 2013 Jun; 15(6):428-32. PubMed ID: 23458624
[TBL] [Abstract][Full Text] [Related]
22. Connexins regulate cell functions in pancreatic stellate cells.
Masamune A; Suzuki N; Kikuta K; Ariga H; Hayashi S; Takikawa T; Kume K; Hamada S; Hirota M; Kanno A; Egawa S; Unno M; Shimosegawa T
Pancreas; 2013 Mar; 42(2):308-16. PubMed ID: 22889984
[TBL] [Abstract][Full Text] [Related]
23. Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.
Kang Z; Wang C; Tong Y; Li Y; Gao Y; Hou S; Hao M; Han X; Wang B; Wang Q; Zhang C
J Med Chem; 2021 Jan; 64(1):629-643. PubMed ID: 33381963
[TBL] [Abstract][Full Text] [Related]
24. HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer.
Cao F; Li J; Sun H; Liu S; Cui Y; Li F
Oncol Rep; 2015 Apr; 33(4):1883-9. PubMed ID: 25672829
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.
Jamshed MB; Munir F; Shahid N; Sadiq U; Muhammad SA; Ghanem NB; Zhong H; Li X; Zhang Q
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G109-G119. PubMed ID: 31736340
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
27. Disruption of Super-Enhancers in Activated Pancreatic Stellate Cells Facilitates Chemotherapy and Immunotherapy in Pancreatic Cancer.
Wang Y; Chen K; Liu G; Du C; Cheng Z; Wei D; Li F; Li C; Yang Y; Zhao Y; Nie G
Adv Sci (Weinh); 2024 Apr; 11(16):e2308637. PubMed ID: 38417121
[TBL] [Abstract][Full Text] [Related]
28. Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model.
Brandes F; Schmidt K; Wagner C; Redekopf J; Schlitt HJ; Geissler EK; Lang SA
BMC Cancer; 2015 Feb; 15():71. PubMed ID: 25884642
[TBL] [Abstract][Full Text] [Related]
29. Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.
Ishii N; Araki K; Yokobori T; Hagiwara K; Gantumur D; Yamanaka T; Handa T; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Harimoto N; Masamune A; Umezawa K; Kuwano H; Shirabe K
Cancer Sci; 2019 Jan; 110(1):334-344. PubMed ID: 30353606
[TBL] [Abstract][Full Text] [Related]
30. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
31. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
Froeling FE; Feig C; Chelala C; Dobson R; Mein CE; Tuveson DA; Clevers H; Hart IR; Kocher HM
Gastroenterology; 2011 Oct; 141(4):1486-97, 1497.e1-14. PubMed ID: 21704588
[TBL] [Abstract][Full Text] [Related]
32. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.
Zhang Y; Liu L; Fan P; Bauer N; Gladkich J; Ryschich E; Bazhin AV; Giese NA; Strobel O; Hackert T; Hinz U; Gross W; Fortunato F; Herr I
Oncotarget; 2015 Apr; 6(12):9999-10015. PubMed ID: 25846752
[TBL] [Abstract][Full Text] [Related]
33. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
34. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells.
Zhang GN; Liang Y; Zhou LJ; Chen SP; Chen G; Zhang TP; Kang T; Zhao YP
Cancer Lett; 2011 Dec; 313(2):137-44. PubMed ID: 22030254
[TBL] [Abstract][Full Text] [Related]
35. RC-3095, a gastrin-releasing peptide receptor antagonist, synergizes with gemcitabine to inhibit the growth of human pancreatic cancer CFPAC-1 in vitro and in vivo.
Hong SK; Yang SY; Yin SH; Yang KX
Pancreas; 2014 Jan; 43(1):15-21. PubMed ID: 24326363
[TBL] [Abstract][Full Text] [Related]
36. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.
Kazim S; Malafa MP; Coppola D; Husain K; Zibadi S; Kashyap T; Crochiere M; Landesman Y; Rashal T; Sullivan DM; Mahipal A
Mol Cancer Ther; 2015 Jul; 14(7):1570-81. PubMed ID: 25934708
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells.
Hering J; Garrean S; Dekoj TR; Razzak A; Saied A; Trevino J; Babcock TA; Espat NJ
Ann Surg Oncol; 2007 Dec; 14(12):3620-8. PubMed ID: 17896154
[TBL] [Abstract][Full Text] [Related]
38. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer.
Kuninty PR; Bansal R; De Geus SWL; Mardhian DF; Schnittert J; van Baarlen J; Storm G; Bijlsma MF; van Laarhoven HW; Metselaar JM; Kuppen PJK; Vahrmeijer AL; Östman A; Sier CFM; Prakash J
Sci Adv; 2019 Sep; 5(9):eaax2770. PubMed ID: 31517053
[TBL] [Abstract][Full Text] [Related]
39. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
[TBL] [Abstract][Full Text] [Related]
40. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
Kunnumakkara AB; Sung B; Ravindran J; Diagaradjane P; Deorukhkar A; Dey S; Koca C; Tong Z; Gelovani JG; Guha S; Krishnan S; Aggarwal BB
Int J Cancer; 2012 Aug; 131(3):E292-303. PubMed ID: 21935918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]